Bruce Hamilton

Bruce Hamilton is an experienced drug development professional currently working as a Drug Development Leader at Labcorp Drug Development. Here are some key details about his background and role:

Professional Experience

Bruce Hamilton has over 25 years of pharmaceutical research and development experience, working in both large pharma companies and biotechs.1 At Labcorp Drug Development, he manages a team of Drug Development Leaders who provide clients with scientific and regulatory advice across a range of pharmaceutical products.1

Areas of Expertise

His areas of expertise include:

• Biological therapies (monoclonal antibodies, cell therapies, gene therapies)
• Oligonucleotides
• Vaccines
• New chemical entities (NCEs)
• Inhaled protein therapies

Previous Roles

Before joining Labcorp, Bruce held positions at several prominent companies in the pharmaceutical and biotech industries, including:

• Director of New Product Development at Abcam
• Roles at Medimmune, Bicycle Therapeutics, GlaxoSmithKline, and Astex Therapeutics1

Key Accomplishments

Throughout his career, Bruce has:

• Been responsible for end-to-end delivery of three compounds from selection to initiation of clinical testing
• Assisted many compounds in progressing through intermediate development milestones
• Managed risk and timelines to accelerate drug development
• Prioritized resources and maximized commercial value potential1

Current Focus

At Labcorp, Bruce specializes in providing scientific advice and oversight for clients' preclinical programs as part of the Early Phase Development Solutions team.2 He has experience in drug development strategy in a CRO environment, dealing with a broad range of modalities.2

Bruce is based in the Greater Cambridge area in the United Kingdom3 and is actively involved in hiring and expanding his team at Labcorp.4